Home
Contact
   Home
Press Releases
More Ascletis News
© 2016 Ascletis. All Rights Reserved
浙公网安备 33010802003344 号
CONTACT US
pr@ascletis.com
hr@ascletis.com
bd@ascletis.com
clinicaltrials@ascletis.com
Contact

Dec 28, 2017   Ascletis was Accredited as a National High-Tech Enterprise  >>

Jan 05, 2018   The Wall Street Journal: Populations of Data Propel China to the Forefront of Biotech >>

20180105TheWallStreet.pdf

Jan 10, 2018   Ascletis  Presented at 2018 J.P.Morgan Healthcare Conference >>

20180110JPMorgan.pdf

Sep 19, 2017   Ascletis Won the First Prize in the China Innovation and Entrepreneurship Competition at Healthcare Sector Final  >>

20170919FirstPrize.pdf 20171228NationalHiTech.pdf

Mar 19, 2018   Dr.Vivian Chen, Former VP of Eli Lilly China Joined Ascletis  >>

Aug 18,2017   Ascletis In-licenses Medivir HCV Drug Candidate  >>

20180319DrChen.pdf 20170818Medivir.pdf

News & Events

Investor

Careers

Pipeline

Partnership

About  Us

About Us

Our Science

OurScience Pipeline Partership Investor Careers
CCTV Report on HCV
Partnership
IHEPA Interview
20170818Medivir.pdf XinyueChen.pdf

Guidelines for the HCV Treatment

GuidelinesForHCV2015.pdf
HIV in China
Video
Corporate Member

Ascletis’ mission is to become a world-class biotechnology company addressing unmet medical needs in three therapeutic areas: anti-viral, cancer and fatty liver disease.

HCV IN CHINA

歌礼与您携手

共同抗击肝炎

Together, Cure Hepatitis

7.28 世界肝炎日

World Hepatitis Day

News & Events

Investor

Careers

Pipeline

Partnership

About  Us

About Us

Our Science

OurScience Pipeline Partership Investor Careers